Impact of Bulky & Liposomal Secukinumab on Lymphocytes of Psoriatic Patients, to Determine the Improvement in Bioavailability of Secukinumab Nanolipo. Am. J. Life Sci. Innov. [Internet]. 2025 Jun. 15 [cited 2026 Apr. 17];4(1):27-35. Available from: https://e-pallipublishers.com/index.php/ajlsi/article/view/3268